Keyword News: [stem cell]

Yahoo! Alerts

Yahoo! News - My Alerts - Edit Alert

Wednesday, April 16, 2008 11:31 PM PDT

Stem Cell Measure May Miss Mo. Ballot KMBC-TV Kansas City Wed, 16 Apr 2008 5:52 PM PDT A proposal to reverse part of a 2006 constitutional amendment allowing embryonic stem cell research appears in jeopardy of not making Missouri's ballot. Molecule Delivery Method Improves Embryonic Stem Cell Differentiation, Georgia Tech-Emory Researchers Say Local Tech Wire Wed, 16 Apr 2008 11:27 AM PDT Editor's note: This article is part of WRAL Local Tech Wire's highlighting of research at universities across the Carolinas and Georgia. ATLANTA - Embryonic stem cell therapies have been proposed for regenerative medicine and tissue replacement after injury or disease. Germany eases ban on embryonic stem-cell lines Nature Wed, 16 Apr 2008 8:19 AM PDT German researchers will be able to use hundreds more human embryonic stem-cell lines following a vote in parliament to amend the country's controversial stem-cell law. Buck Institute And Q Therapeutics Form Stem Cell Collaboration To Combat Parkinson's Disease Medical News Today Wed, 16 Apr 2008 5:13 AM PDT The Buck Institute for Age Research and Q Therapeutics, Inc. announced an agreement to collaborate on novel routes to combat Parkinson's disease. The Buck Institute and Q Therapeutics will use their expertise in differentiating stem cells to provide key cell types needed to study Parkinson's disease. Stem Cell Therapeutics Corp. Congratulates Dr. Samuel Weiss on His Receipt of the Gairdner Award Marketwire via Yahoo! Finance Wed, 16 Apr 2008 10:53 AM PDT Stem Cell Therapeutics Corp. is proud to congratulate Dr. Samuel Weiss, Director of the Hotchkiss Brain Institute at the University of Calgary, for receiving the distinguished Gairdner Award. HepaLife(TM) to Present Bioartificial Liver Device Data at International Stem Cell Conference Centre Daily Times Wed, 16 Apr 2008 6:45 AM PDT HepaLife Technologies, Inc. (OTCBB:HPLF) (FWB:HL1) (WKN:500625) today announced that the Company will present new data from ongoing research and development of its artificial liver device technology at the 6th Annual Meeting of the International Society for Stem Cell Research (ISSCR), June 11-14, 2008. The conference will be held at the Pennsylvania Convention Center in Philadelphia, Pennsylvania. Affitech Participates In The Newly Formed Norwegian Stem Cell-Based Tumour Therapy Center Medical News Today Wed, 16 Apr 2008 2:15 AM PDT Affitech AS, the Norwegian human antibody therapeutics company, announced its membership in the newly inaugurated Norwegian Center for Stem Cell Based Tumor Therapy (CAST). In the frame of this participation, Affitech will use its proprietary CBAS™ (Cell Based Antibody Selection) platform to identify molecules of clinical interest. Cambridge & California in stem cell pact Business Weekly Wed, 16 Apr 2008 2:53 AM PDT Top brains in Cambridge and California have joined forces in a bid to create a true stem cell bank that could offer on-demand delivery of stem cells matched to a patient's own immune system. HepaLife(TM) to Present Bioartificial Liver Device Data at International Stem Cell Conference Business Wire via Yahoo! Finance Wed, 16 Apr 2008 6:15 AM PDT BOSTON----HepaLife Technologies, Inc. today announced that the Company will present new data from ongoing research and development of its artificial liver device technology at the 6th Annual Meeting of the International Society for Stem Cell Research , June 11-14, 2008.

See more news stories that match my keyword

You received this email because you subscribed to Yahoo! Alerts. Use this link to unsubscribe from this alert. To change your communications preferences for other Yahoo! business lines, please visit your Marketing Preferences. To learn more about Yahoo!'s use of personal information, including the use of web beacons in HTML-based email, please read our Privacy Policy. Yahoo! is located at 701 First Avenue, Sunnyvale, CA 94089.